Dinesh V Ph D Patel Protagonist Therapeutics, Inc (PTGX) insider trading activity

PTGX Quotes by TradingView

Dinesh V Ph D Patel is President and CEO of Protagonist Therapeutics, Inc. Currently has a direct ownership of 408,455 shares of PTGX, which is worth approximately $16.9 Million. The most recent transaction as insider was on Dec 21, 2021, when has been sold 15,000 shares (Common Stock) at a price of $32.14 per share, resulting in proceeds of $482,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 408K
20.6% 3M change
23.56% 12M change
Total Value Held $16.9 Million

DINESH V PH D PATEL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 21 2021
SELL
Open market or private sale
$482,100 $32.14 p/Share
15,000 Reduced 3.05%
477,158 Common Stock
Sep 21 2021
BUY
Exercise of conversion of derivative security
$168,400 $4.21 p/Share
40,000 Added 7.52%
492,158 Common Stock
Feb 26 2021
BUY
Grant, award, or other acquisition
-
25,000 Added 5.25%
451,144 Common Stock
Jan 19 2021
SELL
Open market or private sale
$611,212 $24.6 p/Share
24,846 Reduced 5.51%
426,144 Common Stock
Jan 19 2021
BUY
Exercise of conversion of derivative security
$54,730 $4.21 p/Share
13,000 Added 2.8%
450,990 Common Stock
DVP

Dinesh V Ph D Patel

President and CEO
Newark, CA

Track Institutional and Insider Activities on PTGX

Follow Protagonist Therapeutics, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTGX shares.

Notify only if

Insider Trading

Get notified when an Protagonist Therapeutics, Inc insider buys or sells PTGX shares.

Notify only if

News

Receive news related to Protagonist Therapeutics, Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PTGX